Piper Sandler analyst Allison Bratzel upgraded Replimune (REPL) to Overweight from Neutral with a price target of $13, up from $8.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REPL:
- Replimune Group’s FDA Resubmission for RP1 Accepted
- Replimune upgraded to Neutral from Underweight at JPMorgan
- Replimune upgraded to Neutral at JPMorgan after BLA resubmission accepted
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
- Midday Fly By: AWS hit by outage, Kering sells beauty unit